ENDOTHELIN-CONVERTING ENZYME-INHIBITION IN-VITRO AND IN-VIVO BY N-PHOSPHONOMETHYL-LEU-TRP

被引：0
|
作者：
BIGAUD, M [1 ]
BASTIAN, S [1 ]
JAUCH, MF [1 ]
MARCHAL, P [1 ]
DORCHYMONT, H [1 ]
机构：
[1] HOECHST MARION ROUSSEL INC,RES INST,F-67009 STRASBOURG,FRANCE
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1995年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P427 / P427
页数：1
相关论文
共 17 条
  • [1] INHIBITION OF NEUTRAL ENDOPEPTIDASE-24.11 (NEP) AND ENDOTHELIN-CONVERTING ENZYME (ECE) BY AMINOPHOSPHONATE ANALOGS IN-VITRO AND IN-VIVO
    TRAPANI, AJ
    BEIL, ME
    BERRY, C
    DELOMBAERT, S
    GERLOCK, TE
    GHAI, RD
    GRAYBILL, SC
    JENG, AY
    SAKANE, Y
    SAVAGE, P
    [J]. FASEB JOURNAL, 1994, 8 (04): : A104 - A104
  • [2] INHIBITORY ACTIVITIES OF METAL CHELATORS ON ENDOTHELIN-CONVERTING ENZYME .2. IN-VIVO STUDIES
    ASHIZAWA, N
    OKUMURA, H
    KOBAYASHI, F
    AOTSUKA, T
    ASAKURA, R
    ARAI, K
    ASHIKAWA, N
    MATSUURA, A
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1994, 17 (02) : 212 - 216
  • [3] INHIBITORY ACTIVITIES OF METAL CHELATORS ON ENDOTHELIN-CONVERTING ENZYME .1. IN-VITRO STUDIES
    ASHIZAWA, N
    OKUMURA, H
    KOBAYASHI, F
    AOTSUKA, T
    TAKAHASHI, M
    ASAKURA, R
    ARAI, K
    MATSUURA, A
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1994, 17 (02) : 207 - 211
  • [4] SUBSTRATE-SPECIFICITY FOR ANGIOTENSIN CONVERTING ENZYME IN-VIVO AND IN-VITRO
    OPARIL, S
    BARNES, B
    HABER, E
    KOERNER, T
    [J]. FEDERATION PROCEEDINGS, 1972, 31 (02) : A511 - &
  • [5] In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat
    Hubner, RA
    Kubota, E
    Casley, DJ
    Johnston, CI
    Burrell, LM
    [J]. JOURNAL OF HYPERTENSION, 2001, 19 (05) : 941 - 946
  • [6] STRUCTURE-ACTIVITY RELATIONSHIP OF PHOSPHORAMIDON DERIVATIVES FOR IN-VIVO ENDOTHELIN-CONVERTING-ENZYME INHIBITION
    BIGAUD, M
    HAUSS, B
    SCHALK, C
    JAUCH, MF
    DORCHYMONT, H
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (02) : 155 - 161
  • [7] PARTICIPATION OF PROSTAGLANDINS AND BRADYKININ IN THE EFFECTS OF ANGIOTENSIN-II AND CONVERTING ENZYME-INHIBITION ON SYMPATHETIC NEUROTRANSMISSION IN-VIVO
    SCHWIELER, JH
    KAHAN, T
    NUSSBERGER, J
    HJEMDAHL, P
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1994, 152 (01): : 83 - 91
  • [8] STRUCTURAL REQUIREMENTS FOR SUBSTRATES AND INHIBITORS OF ANGIOTENSIN I-CONVERTING ENZYME IN-VIVO AND IN-VITRO
    OPARIL, S
    KOERNER, T
    ODONOGHU.JK
    [J]. CIRCULATION RESEARCH, 1974, 34 (01) : 19 - 26
  • [9] Identification of an Endothelin-converting Enzyme-2-specific Fluorigenic Substrate and Development of an in Vitro and ex Vivo Enzymatic Assay
    Ouimet, Tanja
    Orng, Sou-Vinh
    Poras, Herve
    Gagnidze, Khatuna
    Devi, Lakshmi A.
    Fournie-Zaluski, Marie-Claude
    Roques, Bernard P.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (45) : 34390 - 34400
  • [10] IN-VIVO AND IN-VITRO INHIBITION OF METABOLISM OF N-ALKYL-SUBSTITUTED AMPHETAMINES IN RAT BY FERROCENYLISOPROPYLAMINE
    VREE, TB
    HENDERSON, PT
    VANROSSU.JM
    DOUKAS, PH
    [J]. XENOBIOTICA, 1973, 3 (01) : 23 - 35
12